Inhaled bronchodilators for chronic bronchitis and emphysema
Intended for healthcare professionals
Art & Science Previous     Next

Inhaled bronchodilators for chronic bronchitis and emphysema

Gerri Kaufman Lecturer, Department of Health Sciences, University of York

The article discusses the pharmacology of oral bronchodilators and their role in the management of chronic obstructive pulmonary disease (COPD). Management of acute exacerbations and the importance of follow up and review are considered briefly. The article includes a description of the damage to the airways caused by COPD.

Nursing Standard. 25, 5, 61-68. doi: 10.7748/ns2010.10.25.5.61.c8026

Correspondence

gk8@york.ac.uk

Peer review

This article has been subject to double blind peer review

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more